Theravance Biopharma

CUSIP: g8807b106 Class: COM

Holders for Q4 2025 Position Changes for Q4 2025

Note: Option positions (PUT/CALL) are excluded.

New Positions (1)

Legato Capital Management LLC
Value ($000) $489 Shares 26,157